114 related articles for article (PubMed ID: 31634547)
1. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach.
Strouhalova D; Macejova D; Mosna B; Bobal P; Otevrel J; Lastovickova M; Brtko J; Bobalova J
Toxicol Lett; 2020 Jan; 318():22-29. PubMed ID: 31634547
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells.
Hunakova L; Horvathova E; Majerova K; Bobal P; Otevrel J; Brtko J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857277
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the combined effect of triorganotin compounds and all-trans retinoic acid on expression of selected proteins associated with tumor progression in breast cancer cell line MDA-MB-231: Proteomic approach.
Strouhalova D; Toporova L; Lastovickova M; Macejova D; Bobalova J; Brtko J
Gen Physiol Biophys; 2019 Mar; 38(2):135-144. PubMed ID: 30806631
[TBL] [Abstract][Full Text] [Related]
4. Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231.
Hunakova L; Brtko J
Toxicol Lett; 2017 Sep; 279():16-21. PubMed ID: 28709983
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of tributyltin chloride and triphenyltin chloride in human breast cancer cell lines MCF-7 and MDA-MB-231.
Hunakova L; Macejova D; Toporova L; Brtko J
Tumour Biol; 2016 May; 37(5):6701-8. PubMed ID: 26662104
[TBL] [Abstract][Full Text] [Related]
6. Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics.
Flodrova D; Toporova L; Lastovickova M; Macejova D; Hunakova L; Brtko J; Bobalova J
Toxicol Lett; 2017 Nov; 281():26-34. PubMed ID: 28886987
[TBL] [Abstract][Full Text] [Related]
7. Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 Cells.
Hunakova L; Horvathova E; Gronesova P; Bobal P; Otevrel J; Brtko J
Anticancer Res; 2019 Sep; 39(9):4845-4851. PubMed ID: 31519587
[TBL] [Abstract][Full Text] [Related]
8. Effects of natural ligands and synthetic triorganotin compounds of nuclear retinoid X receptors in human MCF-7 breast cancer cell line.
Macejova D; Toporova L; Brtko J
Gen Physiol Biophys; 2017 Oct; 36(4):481-484. PubMed ID: 28836501
[TBL] [Abstract][Full Text] [Related]
9. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
[TBL] [Abstract][Full Text] [Related]
10. Radioligand binding assay for accurate determination of nuclear retinoid X receptors: A case of triorganotin endocrine disrupting ligands.
Toporova L; Macejova D; Brtko J
Toxicol Lett; 2016 Jul; 254():32-6. PubMed ID: 27153798
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of the human retinoid X receptor by organotins: use of site-directed mutagenesis to identify critical amino acid residues for organotin-induced transactivation.
Hiromori Y; Aoki A; Nishikawa J; Nagase H; Nakanishi T
Metallomics; 2015 Jul; 7(7):1180-8. PubMed ID: 25985376
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
[TBL] [Abstract][Full Text] [Related]
13. Tributyltin and triphenyltin inhibit osteoclast differentiation through a retinoic acid receptor-dependent signaling pathway.
Yonezawa T; Hasegawa S; Ahn JY; Cha BY; Teruya T; Hagiwara H; Nagai K; Woo JT
Biochem Biophys Res Commun; 2007 Mar; 355(1):10-5. PubMed ID: 17291456
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
15. Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions.
Nakanishi T; Nishikawa J; Hiromori Y; Yokoyama H; Koyanagi M; Takasuga S; Ishizaki J; Watanabe M; Isa S; Utoguchi N; Itoh N; Kohno Y; Nishihara T; Tanaka K
Mol Endocrinol; 2005 Oct; 19(10):2502-16. PubMed ID: 15941851
[TBL] [Abstract][Full Text] [Related]
16. Placental steroidogenesis in rats is independent of signaling pathways induced by retinoic acids.
Itoh K; Hiromori Y; Kato N; Yoshida I; Itoh N; Ike M; Nagase H; Tanaka K; Nakanishi T
Gen Comp Endocrinol; 2009 Sep; 163(3):285-91. PubMed ID: 19409899
[TBL] [Abstract][Full Text] [Related]
17. Trialkyltin Rexinoid-X Receptor Agonists Selectively Potentiate Thyroid Hormone Induced Programs of Xenopus laevis Metamorphosis.
Mengeling BJ; Murk AJ; Furlow JD
Endocrinology; 2016 Jul; 157(7):2712-23. PubMed ID: 27167774
[TBL] [Abstract][Full Text] [Related]
18. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of retinoid X receptor with an emphasis on the mediation of organotin poisoning in the Pacific oyster (Crassostrea gigas).
Huang W; Wu Q; Xu F; Li L; Li J; Que H; Zhang G
Gene; 2020 Aug; 753():144780. PubMed ID: 32439374
[TBL] [Abstract][Full Text] [Related]
20. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
Brtko J; Dvorak Z
Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
